{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:34:41Z","timestamp":1783470881481,"version":"3.55.0"},"reference-count":67,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1097\/01.ju.0000140503.11467.8e","type":"journal-article","created":{"date-parts":[[2004,10,8]],"date-time":"2004-10-08T08:02:54Z","timestamp":1097222574000},"page":"1792-1799","source":"Crossref","is-referenced-by-count":94,"title":["IS THERE A SCIENTIFIC BASIS FOR THE THERAPEUTIC EFFECTS OF SERENOA REPENS IN BENIGN PROSTATIC HYPERPLASIA? MECHANISMS OF ACTION"],"prefix":"10.1097","volume":"172","author":[{"given":"A.C.","family":"BUCK","sequence":"first","affiliation":[{"name":"Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1097\/01.ju.0000140503.11467.8e_bib1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jama.280.9.784","article-title":"Courses involving complimentary and alternative medicine at U.S. medical schools","volume":"280","author":"Wetzel","year":"1998","journal-title":"JAMA"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib2","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1056\/NEJMsb022858","article-title":"Botanical medicines\u2014the need for new regulation","volume":"347","author":"Marcus","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib3","series-title":"Encyclopedia of Natural Medicine","author":"Murray","year":"1994"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib4","series-title":"A Reference Guide to Medicinal Plants: Herbal Medicine Past and Present","author":"Crellin","year":"1990"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib5","series-title":"American Hospital Formulary Service, 8th ed","first-page":"457","year":"2004"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib6","first-page":"1335","article-title":"Saw palmetto","volume":"33","author":"Chavez","year":"1998","journal-title":"Hosp Pharmacy"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1017\/S1368980000000549","article-title":"Phytotherapy for benign prostatic hyperplasia","volume":"3","author":"Wilt","year":"2000","journal-title":"Public Health Nutr"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib8","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0022-5347(05)67631-8","article-title":"Saw palmetto for the treatment of men with lower urinary tract symptoms","volume":"163","author":"Gerber","year":"2000","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib9","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0090-4295(99)00593-2","article-title":"Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia","volume":"55","author":"Boyle","year":"2000","journal-title":"Urology"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0094-0143(02)00015-0","article-title":"Herbal medications in the treatment of benign prostatic hyperplasia (BPH)","volume":"29","author":"Fagelman","year":"2002","journal-title":"Urol Clin North Am"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0022-4731(84)90264-4","article-title":"Inhibition of androgen metabolism and binding by a liposterolic extract of \u201cSerenoa repens B\u201d in human foreskin fibroblasts","volume":"20","author":"Sultan","year":"1984","journal-title":"J Steroid Biochem"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib12","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1055\/s-2006-962119","article-title":"Inhibition of 5 a reductase activity by extracts from Sabal serrulata","volume":"55","author":"Duker","year":"1989","journal-title":"Planta Med"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0022-4731(84)90265-6","article-title":"Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate","volume":"20","author":"Carilla","year":"1984","journal-title":"J Steroid Biochem"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1210\/jc.83.1.206","article-title":"A novel coculture model for benign prostatic hyperplasia expressing both isoforms of 5 alpha-reductase","volume":"83","author":"Bayne","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/(SICI)1097-0045(19990901)40:4<232::AID-PROS4>3.0.CO;2-0","article-title":"Serenoa repens (Permixon): a 5alpha-reductase types I and II inhibitor\u2014new evidence in a coculture model of BPH","volume":"40","author":"Bayne","year":"1999","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0960-0760(91)90403-R","article-title":"Partial purification of human prostatic 5alpha-reductase (3-oxo-5 alpha-steroid: NADP+4-ene-oxido-reductase; EC 1.3.1.22) in a stable and active form","volume":"38","author":"Sargent","year":"1991","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0303-7207(95)03526-D","article-title":"5alpha-reductase type I is localized to the outer nuclear membrane","volume":"110","author":"Savory","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1097-0045(199610)29:4<219::AID-PROS3>3.0.CO;2-6","article-title":"Effects of the lipidosterolic extract of Serenoa repens (Permixon) on human prostatic cell lines","volume":"29","author":"Ravenna","year":"1996","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0944-7113(11)80030-9","article-title":"Testosterone 5 \u03b1 reductase inhibition by free fatty acids from Sabal serrulata fruits","volume":"1","author":"Neiderprum","year":"1994","journal-title":"Phytomedicine"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/pros.2990220107","article-title":"Comparison of finasteride (Proscar) 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5alpha reductase inhibition","volume":"22","author":"Rhodes","year":"1993","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib21","first-page":"714","article-title":"Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells","volume":"57","author":"Wang","year":"1997","journal-title":"Cancer Res"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0960-0760(95)00134-L","article-title":"Human prostatic steroid 5 alpha-reductase isoforms\u2014a comparative study of selective inhibitors","volume":"54","author":"Iehle","year":"1995","journal-title":"J Steroid Biochem Molec Biol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0960-0760(94)90074-4","article-title":"Inhibition of the activity of \u2018basic\u2019 5 alpha-reductase (type 1) detected in DU 145 cells and expressed in insect cells","volume":"48","author":"Delos","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0960-0760(95)00184-0","article-title":"Testosterone metabolism in primary cultures of human prostate epithelial cells and fibroblasts","volume":"55","author":"Delos","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-5347(05)67330-2","article-title":"The selectivity and specificity of the actions of the lipidpo-sterolic extract of serenoa repens (Permixon\u00ae) on the prostate","volume":"164","author":"Bayne","year":"2000","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000474426","article-title":"Enzyme activities in tissue of human benign prostatic hyperplasia after three months' treatment with the Sabal serrulata extract IDS 89 (Strogen) or placebo","volume":"31","author":"Weisser","year":"1997","journal-title":"Eur Urol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1097-0045(19981001)37:2<77::AID-PROS3>3.0.CO;2-I","article-title":"Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia","volume":"37","author":"Di Silverio","year":"1998","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1097-0045(199605)28:5<300::AID-PROS5>3.0.CO;2-F","article-title":"Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia","volume":"28","author":"Weisser","year":"1996","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/pros.2990030503","article-title":"Nuclei of stroma: site of highest estrogen concentration in human benign prostatic hyperplasia","volume":"3","author":"Kozak","year":"1982","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1172\/JCI109310","article-title":"Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol","volume":"63","author":"Moore","year":"1979","journal-title":"J Clin Invest"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib31","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0960-0760(93)90259-Y","article-title":"Management of benign prostatic hyperplasia with particular emphasis on aromatase inhibitors","volume":"44","author":"Habernicht","year":"1993","journal-title":"J Steroid Biochem Molec Biol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib32","first-page":"557","article-title":"Effects of estradiol on norepinephrine-induced contraction, alpha adrenoreceptor number and norepinephrine content in the female rabbit urethra","volume":"229","author":"Larsson","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib33","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0022-5347(17)45239-6","article-title":"The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth","volume":"136","author":"Naslund","year":"1986","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib34","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1210\/en.132.6.2407","article-title":"Prolactin mediates estradiol-induced inflammation in the lateral prostate of Wistar rats","volume":"132","author":"Tangbanleukal","year":"1993","journal-title":"Endocrinology"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/phrs.1996.0085","article-title":"Effect of Serenoa repens extract (Permixon) on estradiol\/testosterone-induced experimental prostate enlargement in the rat","volume":"34","author":"Paubert-Braquet","year":"1996","journal-title":"Pharmacol Res"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/endo-100-3-729","article-title":"Evidence for a role in prolactin in prostate and seminal vesicle growth in immature male rats","volume":"100","author":"Negro-Vilar","year":"1977","journal-title":"Endocrinology"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/pros.2990060107","article-title":"Metabolic action of prolactin in regressing prostate: independent of androgen action","volume":"6","author":"Smith","year":"1985","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib38","first-page":"154","article-title":"Influence of the pituitary on prostatic response to androgen in the rat Bull","volume":"96","author":"Grayhack","year":"1955","journal-title":"Johns Hopkins Hosp"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib39","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1210\/endo-120-4-1457","article-title":"Prolactin influence on cytosol and nuclear androgen receptors in the ventral, dorsal, and lateral lobes of the rat prostate","volume":"120","author":"Prins","year":"1987","journal-title":"Endocrinology"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib40","first-page":"71","article-title":"Binding of prolactin to membranes from human prostate. Advances in Urological Oncology and Endocrinology","author":"Blankenstein","year":"1984","journal-title":"Acta Med Ed Congr"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF02255223","article-title":"The lipidosterolic extract from Serenoa repens interferes with prolactin receptor signal transduction","volume":"2","author":"Vacher","year":"1995","journal-title":"J Biomed Sci"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/(SICI)1097-0045(20000401)43:1<49::AID-PROS7>3.0.CO;2-J","article-title":"Pharmacological effects of the lipidosterolic extract of Serenoa repens (Permixon) on rat prostate hyperplasia induced by hyperprolactinaemia: comparison with finasteride","volume":"43","author":"van Coppenolle","year":"2000","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib43","first-page":"96","article-title":"Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia","volume":"66","author":"Theyer","year":"1992","journal-title":"Lab Invest"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/pros.10084","article-title":"Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal proliferation","volume":"52","author":"Kramer","year":"2002","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib45","first-page":"14","article-title":"Application of prostaglandin inhibitors in the therapy of BPH","volume":"13","author":"Varshavski","year":"2002","journal-title":"Eur Urol Today"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0952-3278(97)90548-2","article-title":"Effect of the lipidic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphnuclear neutrophils","volume":"57","author":"Paubert-Braquet","year":"1997","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1569-9056(02)80234-2","article-title":"Effects of the lipido sterolic extract of Serenoa repens (Permixon) on the infiltrating cells and inflammatory markers in prostatic tissue from BPH patients","volume":"1","author":"Vella-Navarette","year":"2002","journal-title":"Eur Urol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib48","first-page":"547","article-title":"Anti-inflammatory activity of sabal fruit extracts prepared with supercritical carbon dioxide","volume":"42","author":"Breu","year":"1992","journal-title":"In vitro antagonists of cyclooxygenase and 5-lipoxygenase metabolism. Arzneimittelforschung"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib49","series-title":"New Trends in Bladder Cancer Chemotherapy. New Trends in BPH Etiopathies","first-page":"293","article-title":"Effects of Permixon\u00ae (Sereprostat\u00ae in Spain) on phospholipase A2 activity and on arachidonic acid metabolism in cultured prostatic cells","author":"Ragab","year":"1987"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/(SICI)1097-0045(19970501)31:2<131::AID-PROS9>3.0.CO;2-Q","article-title":"Intrinsic and extrinsic factors controlling benign prostatic growth","volume":"31","author":"Lee","year":"1997","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib51","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00005392-199707000-00073","article-title":"Resistance to apoptosis and up regulation of Bcl-2 in benign prostatic hyperplasia after androgen deprivation","volume":"158","author":"Cardillo","year":"1997","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib52","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1464-410X.1998.00752.x","article-title":"Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia","volume":"82","author":"Colombel","year":"1998","journal-title":"Br J Urol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.cdd.4400453","article-title":"An elevated bax\/bcl-2-ratio corresponds with the onset of prostate epithelial cell apoptosis","volume":"6","author":"Perlman","year":"1999","journal-title":"Cell Death Differ"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/pros.1091","article-title":"Apoptotic activity of doxazocin on prostate stroma in vitro is mediated through an autocrine expression of TGF beta1","volume":"48","author":"Ilio","year":"2001","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1097-0045(20001101)45:3<259::AID-PROS9>3.0.CO;2-G","article-title":"Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon\u00ae) in benign prostatic hyperplasia","volume":"45","author":"Vacherot","year":"2000","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/41.1.7678025","article-title":"A new method to detect apoptosis in paraffin sections: in situ end-labelling of fragmented DNA","volume":"41","author":"Wijsman","year":"1993","journal-title":"J Histochem Cytochem"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib57","first-page":"60","article-title":"Oncogenes and growth factors in prostate cancer","volume":"3","author":"Gelman","year":"1991","journal-title":"J Natl Inst Health Research"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pros.2990160108","article-title":"Increased expression of genes for basic fibroblast growth factor and transforming growth factor type beta 2 in human benign prostatic hyperplasia","volume":"16","author":"Mori","year":"1990","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib59","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1210\/me.6.12.2123","article-title":"Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin","volume":"6","author":"Yan","year":"1992","journal-title":"Mol Endocrinol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib60","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000019570","article-title":"Effect of the lipidosterolic extract of Serenoa repens (Permixon) and its major components on basic fibroblast growth factor-induced proliferation of cultures of human prostate biopsies","volume":"33","author":"Paubert-Braquet","year":"1998","journal-title":"Eur Urol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1677\/joe.0.1130147","article-title":"Localization of epidermal growth factor receptors in the human prostate by biochemical and immunocytochemical methods","volume":"113","author":"Maddy","year":"1987","journal-title":"J Endocrinol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib62","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0022-5347(17)36032-9","article-title":"Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues","volume":"149","author":"Ibrahim","year":"1993","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00042307-199801000-00005","article-title":"Phytotherapy in the treatment of benign prostatic hyperplasia","volume":"8","author":"Lowe","year":"1998","journal-title":"Curr Opin Urol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib64","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMra020398","article-title":"Herbal remedies","volume":"347","author":"de Smet","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib65","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1464-410X.1996.00104.x","article-title":"Phytotherapy for the prostate","volume":"78","author":"Buck","year":"1996","journal-title":"Br J Urol"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib66","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1097-0045(199610)29:4<231::AID-PROS4>3.0.CO;2-E","article-title":"Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomised international study of 1,098 patients","volume":"29","author":"Carraro","year":"1996","journal-title":"Prostate"},{"key":"10.1097\/01.ju.0000140503.11467.8e_bib67","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0302-2838(02)00066-0","article-title":"Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study","volume":"41","author":"Debruyne","year":"2002","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534705608610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534705608610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1097\/01.ju.0000140503.11467.8e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:53:39Z","timestamp":1651215219000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1097\/01.ju.0000140503.11467.8e"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1097\/01.ju.0000140503.11467.8e"],"URL":"https:\/\/doi.org\/10.1097\/01.ju.0000140503.11467.8e","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}